Article info

PDF

Original article
GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer

Authors

  • Paola Martinelli Epithelial Carcinogenesis Group, Spanish National Cancer Research Center-CNIO, Madrid, Spain Cancer Progression and Metastasis Group, Institute for Cancer Research, Medical University Wien, Vienna, Austria PubMed articlesGoogle scholar articles
  • Enrique Carrillo-de Santa Pau Epithelial Carcinogenesis Group, Spanish National Cancer Research Center-CNIO, Madrid, Spain PubMed articlesGoogle scholar articles
  • Trevor Cox Cancer Research UK Liverpool Clinical Trials Unit, University of Liverpool, Liverpool, UK NIHR Liverpool Pancreas Biomedical Research Unit, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  • Bruno Sainz Department of Preventive Medicine, Public Health and Microbiology, Universidad Autónoma de Madrid, Madrid, Spain PubMed articlesGoogle scholar articles
  • Nelson Dusetti Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France PubMed articlesGoogle scholar articles
  • William Greenhalf NIHR Liverpool Pancreas Biomedical Research Unit, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  • Lorenzo Rinaldi Epithelial Carcinogenesis Group, Spanish National Cancer Research Center-CNIO, Madrid, Spain Institute for Research in Biomedicine (IRB), Barcelona, Spain PubMed articlesGoogle scholar articles
  • Eithne Costello Cancer Research UK Liverpool Clinical Trials Unit, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  • Paula Ghaneh Cancer Research UK Liverpool Clinical Trials Unit, University of Liverpool, Liverpool, UK NIHR Liverpool Pancreas Biomedical Research Unit, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  • Núria Malats Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center-CNIO, Madrid, Spain PubMed articlesGoogle scholar articles
  • Markus Büchler Department for General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany PubMed articlesGoogle scholar articles
  • Marina Pajic Cancer Division, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia PubMed articlesGoogle scholar articles
  • Andrew V Biankin Cancer Division, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK South Western Sydney Clinical School, Faculty of Medicine, University of NSW, Liverpool, Australia PubMed articlesGoogle scholar articles
  • Juan Iovanna Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Technologique de Luminy, Marseille, France PubMed articlesGoogle scholar articles
  • John Neoptolemos Cancer Research UK Liverpool Clinical Trials Unit, University of Liverpool, Liverpool, UK NIHR Liverpool Pancreas Biomedical Research Unit, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  • Francisco X Real Epithelial Carcinogenesis Group, Spanish National Cancer Research Center-CNIO, Madrid, Spain Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Francisco X Real, CNIO, Melchor Fernandez Almagro, 3. Madrid 28029, Spain; freal{at}cnio.es and Dr Paola Martinelli Borschkegasse 8a. 1090 Vienna, Austria; paola.martinelli{at}meduniwien.ac.at
View Full Text

Citation

Martinelli P, Carrillo-de Santa Pau E, Cox T, et al
GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer

Publication history

  • Received 9 December 2015
  • Revised 3 May 2016
  • Accepted 19 May 2016
  • Published in print 1 September 2017.
  • Published online 9 August 2017.
  • Published first 20 June 2016.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.